abstract |
A topical anti-acne formulation comprises, in a pharmaceutical acceptable carrier, a compound of the formula C6H2ClOHR1R2 (10), wherein R1 (16) and R2 (18) are each independently C1 to C7 alkyl, C3 to C7 cycloalkyl or C3 to C7 aryl, and zinc oxide (26). The preferred formulation contains 4-chloro-3,5-dimethylphenol (24) and zinc oxide (26). |